Linking AHK-Cu to bigger, biocompatible carriers that enhance delivery accuracy and shield it from deterioration is one intriguing approach, drawing inspiration from recent developments in nanomaterial-based treatments (Saha et al., 2024)
Research indicates that achieving weight loss can significantly reduce perimenopausal symptoms, including hot flushes, night sweats, and mood swings
Risks and who should avoid it Because GLP-1 microdosing exists entirely outside of FDA-approved guidelines, there is currently no clinical trial data establishing its safety or efficacy
The safest answer is to start with the product label, introduce topicals slowly, and speak with a healthcare professional before using GHK-Cu internally or in clinical formats
Even 15 minutes once or twice a week can set you up for success